Paul J Clancy - Net Worth and Insider Trading

Paul J Clancy Net Worth

The estimated net worth of Paul J Clancy is at least $19 Million dollars as of 2024-04-23. Paul J Clancy is the EVP, CFO of Alexion Pharmaceuticals Inc and owns about 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $17 Million. Paul J Clancy is also the Executive VP and CFO of Biogen Inc and owns about 10,813 shares of Biogen Inc (BIIB) stock worth over $2 Million. Details can be seen in Paul J Clancy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul J Clancy has not made any transactions after 2018-07-10 and currently still holds the listed stock(s).

Transaction Summary of Paul J Clancy

To

Paul J Clancy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul J Clancy owns 6 companies in total, including Incyte Corp (INCY) , Agios Pharmaceuticals Inc (AGIO) , and Alexion Pharmaceuticals Inc (ALXN) among others .

Click here to see the complete history of Paul J Clancy’s form 4 insider trades.

Insider Ownership Summary of Paul J Clancy

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2023-09-29 director
AGIO Agios Pharmaceuticals Inc 2013-09-24 director
ALXN Alexion Pharmaceuticals Inc 2019-07-11 EVP & Chief Financial Officer
BIIB Biogen Inc 2017-04-25 Executive VP and CFO
EXAS Exact Sciences Corp 2021-03-18 director
XLO Xilio Therapeutics Inc 2021-10-21 director

Paul J Clancy Latest Holdings Summary

Paul J Clancy currently owns a total of 2 stocks. Among these stocks, Paul J Clancy owns 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) as of July 10, 2018, with a value of $17 Million and a weighting of 89.07%. Paul J Clancy also owns 10,813 shares of Biogen Inc (BIIB) as of April 25, 2017, with a value of $2 Million and a weighting of 10.93%.

Latest Holdings of Paul J Clancy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2018-07-10 93,309 182.50 17,028,893
BIIB Biogen Inc 2017-04-25 10,813 193.18 2,088,855

Holding Weightings of Paul J Clancy


Paul J Clancy Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,241 shares on July 10, 2018, which brought Paul J Clancy around $687,148.

According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,892 shares on April 25, 2017, which brought Paul J Clancy around $3 Million.

Insider Trading History of Paul J Clancy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul J Clancy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul J Clancy Ownership Network

Ownership Network List of Paul J Clancy

No Data

Ownership Network Relation of Paul J Clancy


Paul J Clancy Owned Company Details

What does Incyte Corp do?

Who are the key executives at Incyte Corp?

Paul J Clancy is the director of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .

Incyte Corp (INCY) Insider Trades Summary

Over the past 18 months, Paul J Clancy made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Incyte Corp Insider Transactions

No Available Data

Paul J Clancy Mailing Address

Above is the net worth, insider trading, and ownership report for Paul J Clancy. You might contact Paul J Clancy via mailing address: C/o Biogen Idec Inc., 14 Cambridge Center, Cambridge Ma 02142.

Discussions on Paul J Clancy

No discussions yet.